share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K:重大事件
美股SEC公告 ·  2024/10/04 05:11

Moomoo AI 已提取核心訊息

Illumina, Inc., a leading company in the biotechnology sector, has announced a significant change in its executive team. On October 3, 2024, the company disclosed the departure of Charles Dadswell, who served as General Counsel and Secretary. Dadswell will transition to an advisory role, supporting the CEO and Board of Directors until March 31, 2025. Scott Davies, previously Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, has been appointed as the Interim General Counsel and Secretary. The company has entered into an Advisory Agreement with Dadswell, ensuring his advisory services until the end of March 2025, for which he will receive his regular compensation and a lump-sum payment of $600,000 upon completion. Additionally, a Separation Agreement outlines further benefits post-termination, including a lump sum equivalent to his annual salary and extended health insurance coverage.
Illumina, Inc., a leading company in the biotechnology sector, has announced a significant change in its executive team. On October 3, 2024, the company disclosed the departure of Charles Dadswell, who served as General Counsel and Secretary. Dadswell will transition to an advisory role, supporting the CEO and Board of Directors until March 31, 2025. Scott Davies, previously Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, has been appointed as the Interim General Counsel and Secretary. The company has entered into an Advisory Agreement with Dadswell, ensuring his advisory services until the end of March 2025, for which he will receive his regular compensation and a lump-sum payment of $600,000 upon completion. Additionally, a Separation Agreement outlines further benefits post-termination, including a lump sum equivalent to his annual salary and extended health insurance coverage.
生物技術板塊的領先公司 Illumina, Inc. 宣佈其高管團隊發生重大變化。2024年10月3日,該公司披露了總法律顧問兼秘書 Charles Dadswell 的離職。Dadswell 將過渡到一個諮詢角色,支持CEO 和董事會,直至2025年3月31日。之前擔任副總法律顧問、首席公司律師兼助理秘書的 Scott Davies 被任命爲臨時總法律顧問兼秘書。該公司已與 Dadswell 簽署了一項諮詢協議,確保他的諮詢服務直至2025年3月底,並將獲得正常報酬以及在完成後獲得60萬美元的一次性支付。此外,一份離職協議概述了終止後的進一步福利,包括一筆等同於他年薪的一次性支付以及延長的健康保險福利。
生物技術板塊的領先公司 Illumina, Inc. 宣佈其高管團隊發生重大變化。2024年10月3日,該公司披露了總法律顧問兼秘書 Charles Dadswell 的離職。Dadswell 將過渡到一個諮詢角色,支持CEO 和董事會,直至2025年3月31日。之前擔任副總法律顧問、首席公司律師兼助理秘書的 Scott Davies 被任命爲臨時總法律顧問兼秘書。該公司已與 Dadswell 簽署了一項諮詢協議,確保他的諮詢服務直至2025年3月底,並將獲得正常報酬以及在完成後獲得60萬美元的一次性支付。此外,一份離職協議概述了終止後的進一步福利,包括一筆等同於他年薪的一次性支付以及延長的健康保險福利。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息